Ansh Labs

Webster, United States Founded: 2010 • Age: 16 yrs Acquired By VION Biosciences
Immunoassay reagents and kits are developed for life science research.

About Ansh Labs

Ansh Labs is a company based in Webster (United States) founded in 2010 was acquired by VION Biosciences in August 2024. The company has 33 employees. Ansh Labs offers products and services including Immunoassays, Antibodies, and Antigens. Ansh Labs operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, PrognomiQ and Stem Cell Technologies, among others.

Key Metrics

Products & Services of Ansh Labs

Ansh Labs offers a comprehensive portfolio of products and services, including Immunoassays, Antibodies, and Antigens.

Immunoassays
Diagnostic Tools

Assays for detecting biomarkers in research and clinical settings.

Antibodies
Biochemicals

Developed for optimal binding in immunoassays.

Antigens
Research Reagents

Components used in immunoassays for biomarker analysis.

Investors in Ansh Labs

Ansh Labs has secured backing from 1 investor. Prominent investors backing the company include VION Biosciences.

All
InvestorDescriptionFounded YearDomainLocation
Provides end-to-end solutions for drug development, diagnostics, and research manufacturing.
2023vionbiosciences.comCharlottesville, United States
Premium access

Investor details for Ansh Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ansh Labs

5 people are tracked at Ansh Labs (5 in team); the tracked headcount is 33.

NameRoleGroup
Felipe Villasenor
EVP Finance & TechnologyTeam
Hetal Parekh
ScientistTeam
Ansh Labs Scientific Affairs
Scientific AffairsTeam
Ashley Torres
Lab techTeam
viraj patel
Senior ScientistTeam
Premium access

Complete people profiles for Ansh Labs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ansh Labs

2 dated milestones of Ansh Labs across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ansh Labs is founded.
  2. Exit Acquired by VION Biosciences.

Competitors of Ansh Labs

Ansh Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, PrognomiQ and Stem Cell Technologies, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abcam.com1998Cambridge, United Kingdom$78.8M405
Biological reagents and antibodies are developed for life science research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
prognomiq.com2020San Mateo, United States$90.36M24
Developer of tests for the detection and treatment of cancer and other diseases
stemcell.com1993Vancouver, Canada$11.92M129
Developer of cell culture media and ancillary reagents for life science research
miltenyibiotec.com1989Bergisch Gladbach, Germany–585
Develops tools and products for research and clinical application
devyser.com2004Stockholm, Sweden$15.48M–
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
teknova.com1996Hollister, United States–290
Molecular biology reagents and kits are supplied for research applications.
meridianbioscience.com1976Ohio, United States––
Molecular diagnostic device and kits
Premium access

Detailed competitors of Ansh Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ansh Labs

The website of Ansh Labs (anshlabs.com) receives about 3.3K visits a month.

  • Monthly visits
    3.3K

    ▼ 4.2% vs previous month

Similar websites

Websites whose visitors overlap most with Ansh Labs. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
epitopediagnostics.com
100%
3.8K#4,690,121View details
poliklinika-harni.hr
poliklinika-harni.hr
99%
–#552,298–
rmdiagnostics.com
94%
–#8,076,423View details
mercodia.com
94%
3.6K#3,052,717View details
phadkelabs.com
phadkelabs.com
79%
–#12,301,838–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 19 similar websites and full traffic analytics for Ansh Labs

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Ansh Labs

Premium access

Complete news archive for Ansh Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Ansh Labs

10 companies that operate in the same segment as Ansh Labs (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ansh Labs

Ansh Labs was founded in 2010.

Ansh Labs is headquartered in Webster, United States. It is registered at Webster, New York, United States.

Ansh Labs has 33 employees.

Ansh Labs was founded in 2010 in Webster, United States, within the biotechnology sector. Immunoassay reagents and kits are produced for life science research, drawing from biomarker studies. Clinical applications are targeted in reproductive medicine, neurodegenerative disorders, and oncology. Support is provided to researchers in translational medicine and clinical diagnostics through these tools.

Ansh Labs's top competitors include Abcam, Sino Biological and Meridian Bioscience.

Ansh Labs offers Immunoassays, Antibodies, and Antigens.

Ansh Labs has 1 investor. Key investors include VION Biosciences.

Yes. Ansh Labs was acquired by VION Biosciences in August 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available